Monsanto (MON) Position Lessened by Gofen & Glossberg LLC IL

Gofen & Glossberg LLC IL cut its holdings in Monsanto (NYSE:MON) by 3.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 55,935 shares of the basic materials company’s stock after selling 1,914 shares during the quarter. Gofen & Glossberg LLC IL’s holdings in Monsanto were worth $6,532,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bruderman Asset Management LLC bought a new stake in Monsanto during the 2nd quarter valued at approximately $116,000. Tower Research Capital LLC TRC boosted its position in Monsanto by 230.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after acquiring an additional 750 shares in the last quarter. Americafirst Capital Management LLC bought a new stake in Monsanto during the 3rd quarter valued at approximately $148,000. Fieldpoint Private Securities LLC boosted its position in Monsanto by 100.6% during the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,575 shares of the basic materials company’s stock valued at $186,000 after acquiring an additional 790 shares in the last quarter. Finally, Loews Corp bought a new stake in Monsanto during the 2nd quarter valued at approximately $202,000. 75.37% of the stock is currently owned by institutional investors.

In other news, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the transaction, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Steven Mizell sold 8,100 shares of Monsanto stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the transaction, the executive vice president now owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by company insiders.

MON has been the topic of several research reports. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research report on Thursday, October 5th. Barclays reaffirmed an “equal weight” rating and set a $124.00 price objective (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Macquarie cut Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $128.00 price objective on shares of Monsanto in a research report on Wednesday, November 15th. Eleven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Monsanto currently has a consensus rating of “Hold” and a consensus price target of $126.40.

Monsanto (MON) opened at $119.70 on Tuesday. Monsanto has a 1-year low of $106.97 and a 1-year high of $122.79. The stock has a market cap of $52,690.00, a P/E ratio of 22.13, a PEG ratio of 1.71 and a beta of 1.04. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05.

Monsanto (NYSE:MON) last released its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business had revenue of $2.66 billion for the quarter, compared to analysts’ expectations of $2.77 billion. During the same quarter in the previous year, the business posted $0.21 earnings per share. Monsanto’s revenue for the quarter was up .3% on a year-over-year basis. sell-side analysts predict that Monsanto will post 5.76 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be issued a dividend of $0.54 per share. The ex-dividend date is Thursday, January 4th. This represents a $2.16 annualized dividend and a dividend yield of 1.80%. Monsanto’s payout ratio is 39.93%.

TRADEMARK VIOLATION WARNING: “Monsanto (MON) Position Lessened by Gofen & Glossberg LLC IL” was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://sportsperspectives.com/2018/01/16/monsanto-mon-position-lessened-by-gofen-glossberg-llc-il.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply